The association between smoking and hypertension in a population-based sample of Vietnamese men

Journal of Hypertension

Volumn 28, Issue 2, 2010, Pages 245-250

  Thuy, Au Bich ^a,b   Blizzard, Leigh ^b   Schmidt, Michael D ^b,c   Luc, Pham Hung ^a   Granger, Robert H ^d   Dwyer, Terence ^e  

^a CAN THO UNIVERSITY OF MEDICINE AND PHARMACY   (Viet Nam)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF GEORGIA   (United States)

^d ROYAL HOBART HOSPITAL   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Dose response relationship; Hypertension; Risk factors; Smoking

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VIET NAM;

EID: 75149123524     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833310e0     Document Type: Article

References (38)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
2. Narkiewicz K, Kjeldsen SE, Hedner T. Is smoking a causative factor of hypertension? Blood Press 2005; 14:69-71.
3. Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Int Med 2003; 138:891-897.
4. Kim JW, Park CG, Hong SJ, Park SM, Rha SW, Seo HS, et al. Acute and chronic effects of cigarette smoking on arterial stiffness. Blood Press 2005; 14:80-85.
5. Binder S, Navratil K, Halek J. Chronic smoking and its effect on arterial stiffness. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008; 152:299-302.
6. Niskanen L, Laaksonen DE, Nyyssönen K, Punnonen K, Valkonen V-P, Fuentes R, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004; 44:859-865.
7. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295:573-577.
8. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999; 33:586-590.
9. Bowman TS, Gaziano JM, Buring JE, Sesso HD. A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 2007; 50:2085-2092.
10. Dochi M, Sakata K, Oishi M, Tanaka K, Kobayashi E, Suwazono Y. Smoking as an independent risk factor for hypertension: a 14-year longitudinal study in male Japanese workers. Tohoku J Exp Med 2009; 217:37-43.
11. Tsai P-S, Ke T-L, Huang C-J, Tsai J-C, Chen P-L, Wang S-Y, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23:1355-1360.
12. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure evidence from the health survey for England. Hypertension 2001; 37:187-193.
13. John U,MeyerC,HankeM, VölzkeH, SchumannA.Smoking status, obesity and hypertension in a general [population sample: a cross-sectional study]. Q J Med 2006; 99:407-415.
14. Ng N, Stenlund H, Bonita R, Hakimi M, Wall S, Weinehall L. Preventable risk factors for noncommunicable diseases in rural Indonesisa: prevalence study using WHO STEPS approach. Bull World Health Organ 2005; 84:305-313.
15. Hughes K, Choo M, Kuperan P, Ong C, Aw T. Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore. Atherosclerosis 1998; 137:253-258.
16. Okubo Y, Miyamoto T, Suwazono Y, Kobayashi E, Nogawa K. An association between smoking habits and blood pressure in normotensive Japanese men. J Hum Hypertens 2002; 16:91-96.
17. Goldbourt U, Medalie JH. Characteristics of smokers, nonsmokers, and ex-smokers among 10,000 adult males in Israel II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol 1977; 105:75-86.
18. Imamura H, Tanaka K, Hirae C, Futagami T, Yoshimura Y, Uchida K, et al. Relationship of cigarette smoking to blood pressure and serum lipids and lipoprotein in men. Clin Exp Pharmacol Physiol 1996; 23:397-402.
19. Singh R, Suh I, Singh V, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens 2000; 14:749-763.
20. Jenkins CNH, Dai PX, Ngoc DH, VanKinh H, Hoang TT, Bales S, et al. Tobacco use in Vietnam: prevalence, predictors, and the role of the transnational tobacco corporations. JAMA 1997; 277:1726-1731.
21. WHO Regional Office forthe Western Pacific. Country profiles on tobacco or health 2000. Manila: World Health Organization 2000.
22. Pham LH, Au TB, Blizzard L, Truong NB, Schmidt MD, Granger RH, et al. Prevalence of risk factors for noncommunicable diseases in the Mekong Delta, Vietnam: results from a STEPS survey. BMC Public Health 2009; 9:291.
23. The STEPS Mannual. Geneva: World Health Organisation; 2005 [updated 2005; cited 2007 Dec 13]. Available from: http://www.who.int/chp/steps/ riskfactor/en/index.html.
24. Dictionary of Cancer Terms. National Cancer Institute. US National Insitute of Health; 2009 [updated 2009; cited 2009 Feb 23]. Available from: http:// www.cancer.gov/Templates/db-alpha.aspx?CdrID=306510.
25. Narkiewicz K, Borne PJHvd, Hausberg M, Cooley RL, Winniford MD, Davison DE, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98:528-534.
26. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90:248-253.
27. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong nonsmokers. J Epidemiol Commun Health 1978; 32:303-313.
28. Hayes AW (ed.) Principles and methods of toxicology, 3rd ed. New York: Raven Press; 1994.
29. Tachmes L, Fernandez RJ, Sackner MA. Hemodynamic effects of smoking cigarettes of high and low nicotine content. Chest 1978; 74:243-246.
30. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-2155.
31. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis. JAMA 1998; 279:119-124.
32. Rywik SL, Williams OD, Pajak A, Broda G, Davis CE, Kawalec E, et al. Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project. J Hypertens 2000; 18:999-1006.
33. Istvan JA, Lee WW, Buist AS, Connett JE. Relation of salivary cotinine to blood pressure in middle-aged cigarette smokers. Am Heart J 1999; 137:928-931.
34. Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, et al. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart study. Hypertension 2006; 47:403-409. (Pubitemid 43740282)
35. Lee DH, Ha MH, Kim JR, Jacobs DR Jr. Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension 2001; 37:194-198.
36. Janzon E, Hedblad B, Berglund G, EngstromG.Changes in blood pressure and body weight following smoking cessation in women. J Intern Med 2004; 255:266-272.
37. Bentley B. A review of methods to measure dietary sodium intake. J Cardiovasc Nurs 2006; 21:63-67.
38. Garvey AJ, Ward KD, Bliss RE, Rosner B, Vokonas PS. Relation between saliva cotinine concentration, cigarette consumption, and blood pressure among smokers. Am J Cardiol 1995; 76:95-97.